What is PharmX Technologies Earnings Yield (Joel Greenblatt) %?
PharmX Technologies's Enterprise Value for the quarter that ended in Dec. 2024 was A$40.00 Mil.
PharmX Technologies's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.21 Mil. PharmX Technologies's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2024 was 0.00%.
The historical rank and industry rank for PharmX Technologies's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
ASX:PHX'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -23.85 Med: 1.77 Max: 14713.96
Current: 0.48
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of PharmX Technologies was 14713.96%. The lowest was -23.85%. And the median was 1.77%.
ASX:PHX's Earnings Yield (Joel Greenblatt) % is ranked worse than 63.23% of 688
companies
in the Healthcare Providers & Services industry
Industry Median: 2.76
vs ASX:PHX: 0.48
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. PharmX Technologies's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2024 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
PharmX Technologies Earnings Yield (Joel Greenblatt) % Historical Data
The historical data trend for PharmX Technologies's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PharmX Technologies's Earnings Yield (Joel Greenblatt) %
For the Health Information Services subindustry, PharmX Technologies's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmX Technologies's Earnings Yield (Joel Greenblatt) % Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where PharmX Technologies's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
PharmX Technologiess Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Jun. 2024 is calculated as
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
PharmX Technologies Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of PharmX Technologies's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
PharmX Technologies Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:PHX has been successfully added to your 